Strides Pharma: NCLT Approves Arco Lab Demerger

The National Company Law Tribunal (NCLT) Bengaluru Bench has approved the Scheme of Arrangement for the demerger of the Demerged Undertaking of Arco Lab Private Limited, a wholly-owned subsidiary of Strides Pharma Science Limited, into Pivot Path Private Limited. The final order was made available on the NCLT portal on May 20, 2026. Upon receipt of the certified order and filing with the Registrar of Companies, the Scheme will become effective. Pivot Path will become a wholly-owned subsidiary of Strides, and its shares will be allotted to Strides as per the Scheme. The Demerged Undertaking from Arco Lab will vest with Pivot Path effective April 10, 2025.